Silverio Tomao

Pubblicazioni

Titolo Pubblicato in Anno
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach CANCER IMMUNOLOGY, IMMUNOTHERAPY 2023
The value of the multidisciplinary team in metastatic renal cell carcinoma: Paving the way for precision medicine in toxicities management FRONTIERS IN ONCOLOGY 2023
The management of oligometastatic disease in colorectal cancer: present strategies and future perspectives CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY 2023
Sexual dysfunctions in breast cancer patients: evidence in context SEXUAL MEDICINE REVIEWS 2023
The role of CXCL12 axis in pancreatic cancer: New biomarkers and potential targets FRONTIERS IN ONCOLOGY 2023
Angiogenic factors as prognostic markers in neuroendocrine neoplasms ENDOCRINE 2022
Immune effects of CDK4/6 inhibitors in patients with HR+/HER2− metastatic breast cancer: relief from immunosuppression is associated with clinical response EBIOMEDICINE 2022
The potential role of genomic signature in stage II relapsed colorectal cancer (CRC) patients: a mono-institutional study CANCER MANAGEMENT AND RESEARCH 2022
A 17-gene expression signature for early identification of poor prognosis in clear cell renal cell carcinoma CANCERS 2022
Immunotherapy for Aggressive and Metastatic Pituitary Neuroendocrine Tumors (PitNETs): State-of-the Art CANCERS 2022
Angioside: the role of angiogenesis and hypoxia in lung neuroendocrine tumours according to primary tumour location in left or right parenchyma JOURNAL OF CLINICAL MEDICINE 2022
The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy FRONTIERS IN IMMUNOLOGY 2022
Capecitabine and Temozolomide (CAPTEM) in advanced neuroendocrine neoplasms (NENs): a systematic review and pooled analysis CANCER MANAGEMENT AND RESEARCH 2022
The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter Prospective Study CANCERS 2022
Palliative- and non-palliative indications for glucocorticoids use in course of immune-checkpoint inhibition. Current evidence and future perspectives CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 2021
Weekly chemotherapy as first line treatment in frail head and neck cancer patients in the immunotherapy era JOURNAL OF TRANSLATIONAL MEDICINE 2021
Metastatic renal cell carcinoma management: from molecular mechanism to clinical practice FRONTIERS IN ONCOLOGY 2021
In vivo imaging-based techniques for early diagnosis of oral potentially malignant disorders—systematic review and meta-analysis INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2021
Role of chemotherapy in vulvar cancers: time to rethink standard of care? CANCERS 2021
Capecitabine in treating patients with advanced, persistent, or recurrent cervical cancer: an active and safe option? EXPERT OPINION ON DRUG SAFETY 2021

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma